Diagnosis of head and neck cancer by AI-based tumor-educated platelet RNA profiling of liquid biopsies
Over 95% of head and neck cancers are squamous cell carcinoma (HNSCC). HNSCC is mostly diagnosed late, causing a poor prognosis despite the application of invasive treatment protocols. Tumor-educated platelets (TEPs) have been shown to hold promise as a molecular tool for early cancer diagnosis. We sequenced platelet mRNA isolated from blood of 101 patients with HNSCC and 101 propensity-score matched noncancer controls. Two independent machine learning classification strategies were employed using a training and validation approach to identify a cancer predictor: a particle swarm optimized support vector machine (PSO-SVM) and a least absolute shrinkage and selection operator (LASSO) logistic regression model. The best performing PSO-SVM predictor consisted of 245 platelet transcripts and reached a maximum area under the curve (AUC) of 0.87. For the LASSO-based prediction model, 1,198 mRNAs were selected, resulting in a median AUC of 0.84, independent of HPV status. Our data show that TEP RNA classification by different AI tools is promising in the diagnosis of HNSCC.
Authors
- Johannes A. Langendijk (ORCID: https://orcid.org/0000-0003-1083-372X)
- Robert Paul Takes (ORCID: https://orcid.org/0000-0003-4784-0499)
- Steven W. Mes
- Thomas Klausch (ORCID: https://orcid.org/0000-0001-8771-1742)
- Myron G. Best (ORCID: https://orcid.org/0000-0002-1230-8673)
- Elisabeth Bloemena (ORCID: https://orcid.org/0000-0002-0221-9538)
- Jos B. Poell (ORCID: https://orcid.org/0000-0003-1776-3779)
- Sjors G. J. G. In ‘t Veld (ORCID: https://orcid.org/0000-0002-3680-8437)
- Edward P. Post (ORCID: https://orcid.org/0000-0002-5782-8736)
- Irma M. Verdonck‐de Leeuw (ORCID: https://orcid.org/0000-0002-4507-4607)
- Robert J. Baatenburg de Jong (ORCID: https://orcid.org/0000-0001-7236-264X)
- C. René Leemans (ORCID: https://orcid.org/0000-0001-7887-083X)
- C.H.J. Terhaard (ORCID: https://orcid.org/0000-0001-6062-5457)
- Niels E. Wondergem (ORCID: https://orcid.org/0000-0002-4504-2170)
- Ruud H. Brakenhoff (ORCID: https://orcid.org/0000-0003-3251-5378)
- Femke Lamers (ORCID: https://orcid.org/0000-0003-4344-5766)
- Wessel N. van Wieringen (ORCID: https://orcid.org/0000-0002-5100-9123)
- Thomas Würdinger
Institutions
- Netherlands Institute for Neuroscience (NL)
- University Medical Center Groningen (NL)
- Radboud University Nijmegen (NL)
- Dutch Cancer Society (NL)
- Erasmus MC (NL)
- Radboud University Medical Center (NL)
- Academic Center for Dentistry Amsterdam (NL)
- University Medical Center Utrecht (NL)
- Amsterdam Neuroscience (NL)
- Center for Translational Molecular Medicine (NL)
- Amsterdam University Medical Centers (NL)
- Cancer Center Amsterdam (NL)
- Vrije Universiteit Amsterdam (NL)
- Erasmus University Rotterdam (NL)
Publication Details
- Journal
- JCI Insight
- Published
- 2025-11-27
- DOI
- https://doi.org/10.1172/jci.insight.186680
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00